{"canonical":"https://abierto.us/vendors/essential-access-health-knvjqy9uh316","key":"KNVJQY9UH316","name":"ESSENTIAL ACCESS HEALTH","uei":"KNVJQY9UH316","city":"LOS ANGELES","state":"CA","awards":6,"obligated":"7216.25","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541714","cage":"335K4","parent_name":"ESSENTIAL ACCESS HEALTH","also_known_as":[],"country":"USA","actions":10,"first_action":"2024-02-08","last_action":"2026-08-27","breakdowns":{"naics":[{"key":"541714","name":null,"awards":3,"obligated":"20778.71"},{"key":"541712","name":null,"awards":3,"obligated":"-13562.46"}],"places":[{"key":"CA","name":null,"awards":5,"obligated":"7216.25"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":6,"obligated":"7216.25"}],"award_types":[{"key":"DELIVERY ORDER","name":null,"awards":5,"obligated":"7216.25"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":6,"obligated":"7216.25"}],"product_service_codes":[{"key":"AN12","name":null,"awards":3,"obligated":"20778.71"},{"key":"AN11","name":null,"awards":3,"obligated":"-13562.46"}]},"awards_list":[{"award_key":"CONT_AWD_75N94020F00001_7529_75N94020D00015_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N94020F00001_7529_75N94020D00015_7529/","piid":"75N94020F00001","parent_piid":"75N94020D00015","award_type":"DELIVERY ORDER","vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2024-06-20","last_action_date":"2026-07-23","actions":4,"obligated":"20778.71","current_total_value":"62896.71","potential_total_value":"62896.71","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":18,"description":"CORE FUNCTION ACTIVITIES","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_75N94023F00001_7529_75N94020D00015_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N94023F00001_7529_75N94020D00015_7529/","piid":"75N94023F00001","parent_piid":"75N94020D00015","award_type":"DELIVERY ORDER","vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2024-09-26","last_action_date":"2025-03-26","actions":2,"obligated":"0","current_total_value":"349327.00","potential_total_value":"349327.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":15,"description":"OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_75N94020D00015_7529","permalink":"https://www.usaspending.gov/award/CONT_IDV_75N94020D00015_7529/","piid":"75N94020D00015","parent_piid":null,"award_type":null,"vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2026-07-22","last_action_date":"2026-07-22","actions":1,"obligated":"0","current_total_value":null,"potential_total_value":"5000000.00","naics":"541714","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":18,"description":"EO 14398 -TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYOMATA, AND DEVELOPMENT OF RESEARCH PROTOCO","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSN27500003_7529_HHSN275201300022I_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSN27500003_7529_HHSN275201300022I_7529/","piid":"HHSN27500003","parent_piid":"HHSN275201300022I","award_type":"DELIVERY ORDER","vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2026-08-27","last_action_date":"2026-08-27","actions":1,"obligated":"-0.39","current_total_value":"743361.61","potential_total_value":"743361.61","naics":"541712","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":1,"description":"NICHD: R&D: CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION, MAIN STUDY: NON-SEVERABLE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSN27500002_7529_HHSN275201300022I_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSN27500002_7529_HHSN275201300022I_7529/","piid":"HHSN27500002","parent_piid":"HHSN275201300022I","award_type":"DELIVERY ORDER","vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2024-11-04","last_action_date":"2024-11-04","actions":1,"obligated":"-5655.39","current_total_value":"1420018.61","potential_total_value":"1420018.61","naics":"541712","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":20,"description":"A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_AWD_HHSN27500001_7529_HHSN275201300022I_7529","permalink":"https://www.usaspending.gov/award/CONT_AWD_HHSN27500001_7529_HHSN275201300022I_7529/","piid":"HHSN27500001","parent_piid":"HHSN275201300022I","award_type":"DELIVERY ORDER","vendor_key":"KNVJQY9UH316","recipient_name":"ESSENTIAL ACCESS HEALTH","recipient_uei":"KNVJQY9UH316","recipient_cage":"335K4","recipient_city":"LOS ANGELES","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NATIONAL INSTITUTES OF HEALTH NICHD","office_key":"o-75N940","first_action_date":"2024-02-08","last_action_date":"2024-02-08","actions":1,"obligated":"-7906.68","current_total_value":"143477.42","potential_total_value":"143477.42","naics":"541712","psc":"AN11","extent_competed":"FULL AND OPEN COMPETITION","set_aside":null,"offers_received":20,"description":"CORE FUNCTION ACTIVITIES","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":6,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}